Pharmaceutical

Innorna's mRNA Therapy for Wilson's Disease Gains FDA Boost
Clinical & Pharma Innorna's mRNA Therapy for Wilson's Disease Gains FDA Boost

Innorna, a biotechnology firm from China, has made significant strides in developing an mRNA therapeutic called IN013, designed specifically for Wilson's disease. This progressive step has been further empowered by the US Food and Drug Administration (FDA), which has conferred rare pediatric

Is Targeted Protein Degradation the Future of Medicine?
Clinical & Pharma Is Targeted Protein Degradation the Future of Medicine?

Targeted Protein Degradation (TPD) is ushering in a transformative era in medicine by offering innovative therapeutic strategies that focus on eliminating disease-causing proteins. Unlike traditional therapies that aim to inhibit protein activity, TPD proposes the removal of harmful proteins, which

Rising Costs and US Tariffs Strain Malaysian GP Clinics
Clinical & Pharma Rising Costs and US Tariffs Strain Malaysian GP Clinics

Private general practitioner (GP) clinics in Malaysia are grappling with intense financial pressures exacerbated by rising costs and global trade instability. Significant among these challenges is the looming potential expansion of US tariffs to pharmaceuticals. This situation poses severe

Will FDA's AI-Driven Move End Animal Testing in Drug Development?
Clinical & Pharma Will FDA's AI-Driven Move End Animal Testing in Drug Development?

The announcement from the U.S. Food and Drug Administration (FDA) to gradually phase out animal testing marks a revolutionary shift in drug development. This groundbreaking change aims to replace traditional testing methods with artificial intelligence (AI) and other advanced technologies,

Evolution and Future Trends of U.S. Private Healthcare
Management & Administration Evolution and Future Trends of U.S. Private Healthcare

The evolution of the U.S. private healthcare system is a tale of continual adaptation and innovation, shaped by market dynamics, regulatory changes, and technological advances. This comprehensive overview charts the history from the early foundations to emerging future trends in the industry. In

IBD Patients Face Insurance Barriers Hindering Treatment Adherence
Tech & Innovation IBD Patients Face Insurance Barriers Hindering Treatment Adherence

Patients with Inflammatory Bowel Disease (IBD) often grapple with a myriad of challenges that impede their access to timely and effective medical care. Recent studies presented at the Crohn's & Colitis Congress in 2025 have brought to light the significant barriers that insurance issues

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later